Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Coldstream Laboratories | Contract Pharma
Breaking News, Promotions & Moves

Coldstream Laboratories

Pramod Gupta, Ph.D. has been appointed vice president of quality and chief scientific officer, Coldstream Laboratories, Inc. (CLI).

Pramod Gupta, Ph.D. has been appointed vice president of quality and chief scientific officer, Coldstream Laboratories, Inc. (CLI). In his new role, Dr. Gupta will focus on strengthening the company’s quality systems, R&D capabilities and overall project execution.

Dr. Gupta has more than 20 years of experience in the pharmaceutical and medical device industries. Most recently, he served as vice president of R&D at Bausch & Lomb with focus on the global development of drugs and devices. Previously, he held leadership positions at Baxter Healthcare Corp., TAP Pharmaceuticals and Abbott Laboratories. He has been involved with the development, approval and commercialization of more than 30 drug and medical products.

Joe Wyse, president and chief executive officer of CLI, said, “I am pleased to have recruited Dr. Gupta at this critical stage of Coldstream’s growth. His extensive industry experience and successful track record will be key to achieving our goal of becoming a leader in research, development and manufacture of clinical and commercial healthcare products.His record of excellence in R&D, technology transfer and regulatory interactions will greatly benefit our organization and our partners.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters